Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer
- 18 September 2012
- journal article
- research article
- Published by Elsevier in Journal of Proteomics
- Vol. 75 (17) , 5342-5355
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Center Research Core Facility
- National Cancer Center Research and Development Fund (23-A-10)
This publication has 30 references indexed in Scilit:
- Increased Plasma Levels of the APC-Interacting Protein MAPRE1, LRG1, and IGFBP2 Preceding a Diagnosis of Colorectal Cancer in WomenCancer Prevention Research, 2012
- Targeted In-Gel MRM: A Hypothesis Driven Approach for Colorectal Cancer Biomarker Discovery in Human FecesJournal of Proteome Research, 2010
- Novel Proteomic Strategy Reveal Combined α1 Antitrypsin and Cathepsin D as Biomarkers for Colorectal Cancer Early ScreeningJournal of Proteome Research, 2010
- An Integrative -omics Approach to Identify Functional Sub-Networks in Human Colorectal CancerPLOS Computational Biology, 2010
- Oncogenic function of microtubule end‐binding protein 1 in breast cancerThe Journal of Pathology, 2009
- Genetic prognostic and predictive markers in colorectal cancerNature Reviews Cancer, 2009
- Proteomic profiling reveals the prognostic value of adenomatous polyposis coli–end-binding protein 1 in hepatocellular carcinomaHepatology, 2008
- Proteome Analysis of Membrane Fractions in Colorectal Carcinomas by Using 2D-DIGE Saturation LabelingJournal of Proteome Research, 2008
- EB1 acts as an oncogene via activating β‐catenin/TCF pathway to promote cellular growth and inhibit apoptosisMolecular Carcinogenesis, 2008
- Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancerProteomics, 2006